RxDoctor Payments Data

Emily Ross, APRN

Family · Bowling Green, KYNPI 1104331016

Payments from drug & device makers

$1,285in general payments, 2019–2025

Across 97 payments — averaging $13.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$431
  • GSK$158
  • Mylan Specialty L.p.$143
  • Lilly USA, LLC$133
  • AstraZeneca$118
  • Boehringer Ingelheim$51
  • plus $250 from 11 others

What the payments were for

  • Food & beverage$1,285100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,285 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$5,084
Medicare patients
23
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide99$104,955
JanuviaSitagliptin Phosphate31$21,470
OzempicSemaglutide18$15,799
EliquisApixaban13$14,605
FarxigaDapagliflozin Propanediol21$13,913
Repatha SureclickEvolocumab13$6,957
Dexlansoprazole DrDexlansoprazole26$4,568
Ventolin HfaAlbuterol Sulfate14$786
Nystatin15$718
Levothyroxine Sodium75$677
Albuterol Sulfate HfaAlbuterol Sulfate17$644
Atorvastatin Calcium117$632
Lisinopril68$560
Metoprolol Succinate40$557
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$530

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$133$104,95599 claims
MerckJanuvia$14$21,47031 claims
Novo NordiskOzempic$431$15,79918 claims
PfizerEliquis$28$14,60513 claims
AstraZenecaFarxiga$118$13,91321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →